Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H37NO2 |
Molecular Weight | 323.5133 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC\C=C/C\C=C/CCCCCCCC(=O)NCCO
InChI
InChIKey=KQXDGUVSAAQARU-HZJYTTRNSA-N
InChI=1S/C20H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-18-19-22/h6-7,9-10,22H,2-5,8,11-19H2,1H3,(H,21,23)/b7-6-,10-9-
Molecular Formula | C20H37NO2 |
Molecular Weight | 323.5133 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Optical Activity | NONE |
Linoleic monoethanolamide (or linoleoyl ethanolamide), an endocannabinoid, which weakly binds to CB1 and CB2 receptors. It was used as a neuroprotective agent in a rat model for stroke and acted through an intracellular mechanism independent of the classic endocannabinoid pathways. In addition, was shown, that linoleoyl ethanolamide was not useful in assessing pain in patients with chronic pancreatic diseases and it couldn’t replace a simple method such as a visual analogic scale for assessing the pain and its intensity.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P21554|||Q5UB37 Gene ID: 1268.0 Gene Symbol: CNR1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/9876105 |
10.0 µM [Ki] | ||
Target ID: P34972 Gene ID: 1269.0 Gene Symbol: CNR2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/9876105 |
25.0 µM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability. | 1998 Dec 31 |
|
Fatty acid amide signaling molecules. | 2010 Oct 15 |
|
Lauroylethanolamide and linoleoylethanolamide improve functional outcome in a rodent model for stroke. | 2011 Apr 4 |
|
Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat. | 2014 Aug |
|
Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in those with pancreatic ductal adenocarcinoma. | 2017 Oct |
|
Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women. | 2018 Nov |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21296126
Male Sprague Dawley rats pretreatment, 6 hours and 30 minutes with inoleoylethanolamide (NAE 18:2) before middle cerebral artery occlusion.
Route of Administration:
Intraperitoneal
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:36:17 GMT 2023
by
admin
on
Fri Dec 15 18:36:17 GMT 2023
|
Record UNII |
889DYX0816
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID10887223
Created by
admin on Fri Dec 15 18:36:17 GMT 2023 , Edited by admin on Fri Dec 15 18:36:17 GMT 2023
|
PRIMARY | |||
|
269-029-6
Created by
admin on Fri Dec 15 18:36:17 GMT 2023 , Edited by admin on Fri Dec 15 18:36:17 GMT 2023
|
PRIMARY | |||
|
68171-52-8
Created by
admin on Fri Dec 15 18:36:17 GMT 2023 , Edited by admin on Fri Dec 15 18:36:17 GMT 2023
|
PRIMARY | |||
|
5283446
Created by
admin on Fri Dec 15 18:36:17 GMT 2023 , Edited by admin on Fri Dec 15 18:36:17 GMT 2023
|
PRIMARY | |||
|
64032
Created by
admin on Fri Dec 15 18:36:17 GMT 2023 , Edited by admin on Fri Dec 15 18:36:17 GMT 2023
|
PRIMARY | |||
|
889DYX0816
Created by
admin on Fri Dec 15 18:36:17 GMT 2023 , Edited by admin on Fri Dec 15 18:36:17 GMT 2023
|
PRIMARY |